Form EFFECT Aerovate Therapeutics,
| UNITED STATES | |
| SECURITIES AND EXCHANGE COMMISSION | |
| Washington, D.C. 20549 | |
| Notice of Effectiveness | |
| Effectiveness Date: | March 25, 2025 4:15 P.M. |
| Form: | S-4 | ||||||
| |||||||
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Hexaware Reports Q3CY26 Revenue at USD 411.9 Mn, Up 4.3% YoY
- KBRA Assigns Preliminary Ratings to IGS Solar Shamrock Issuer 2026-1, LLC
- Thanks A Million: Mazda Toyota Manufacturing Celebrates One Millionth Vehicle by Giving Back to Community
Create E-mail Alert Related Categories
SEC FilingsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!





Tweet
Share